Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole ER vs Ranitidine for Maintenance of Healed eGERD
NCT00839306Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in erosive gastroesophageal reflux disease, sponsored by Eisai Co., Ltd.. Started Aug 2008; status: completed.
02
Drugs
rabeprazole
03
Conditions
erosive gastroesophageal reflux disease
Beyond the preview
Go deeper on NCT00839306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839306.